Letters

Cost effectiveness rapidly becomes cost containment

BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.6997.126d (Published 08 July 1995) Cite this as: BMJ 1995;311:126
  1. Kerry D Bell,
  2. Mendel P Grobler
  1. Chief executive officer Health economics manager Australian Pharmaceutical Manufacturers Association, North Sydney, NSW 2060, Australia

    EDITOR,--We believe that Nick Freemantle and colleagues' editorial on promoting cost effective prescribing may give an unrepresentative perception of Australian experience.1 The policy of requiring economic analysis before being prepared to reimburse the cost of an intervention when resources are limited is laudable for many reasons. This policy as applied in Australia can be praised particularly for its theoretical objectives. However, use of this policy as a rationale …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe